Navigation Links
BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock
Date:5/13/2009

SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the pricing of its public offering of 16,000,000 shares of its common stock at $10.40 per share. The offering is expected to close on or about May 18, 2009. Gross proceeds from the offering will be approximately $166.4 million. BioMed expects to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its $600.0 million unsecured line of credit and for other general corporate and working capital purposes. All of the shares are being sold by the company.

BioMed has also granted the underwriters a 30-day option to purchase up to an additional 2,400,000 shares to cover over-allotments, if any. Raymond James & Associates, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. Incorporated, UBS Securities LLC, Wachovia Capital Markets, LLC and Credit Suisse Securities (USA) LLC are the joint book-running managers for the offering.

The registration statement relating to these securities has become effective by rule of the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the offered shares, nor shall there be any sale of such shares in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or other jurisdiction. The offering of BioMed's common stock will be made only by means of a prospectus and a related prospectus supplement, copies of which may be obtained by contacting Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, FL 33716, or by calling toll-free at 1 (800) 248-8863; KeyBanc Capital Markets Inc., 800 Superior Avenue, 17th Floor, Cleveland, Ohio 44114, t
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ithout need to fly far for food, wing shapes chang..., Dec. 3 (HealthDay News) -- Many people think evo... but it can happen much faster and new research sh...n winter appears to be having an effect on a popul...r findings in the Dec. 3 online edition of Curren...
(Date:12/3/2009)..., , WASHINGTON, Dec. 3 /PRNewswire-USNewswir...use and Public Campaign: ,, U.S. Senate Judicia...ering an amendment to the health care reform bill ...legal exemptions for violations such as price fixi...ce industry fiercely opposes the repeal, which wou...
(Date:12/3/2009)... The relatively low number of new cases created by...tigation strategies such as vaccination, social di...o lessen the final impact of the virus, suggests a....ca/cgi/doi/10.1503/cmaj.091807 reported in CMA...maj.ca . , The study looked at data from labora...
(Date:12/3/2009)... Each year, editors of the...octors on its editorial board, choose the top 10 h...ems on the list for 2009. , ...ditors of the Harvard Health Letter , in consulta...se the top 10 health stories of the year. Here are...
(Date:12/3/2009)... Henninger,s creative staf...rds for full production work and 5 awards for post...PRWEB) December 3, 2009 -- The 13th Annual TIVA Pe...squo;s best at the National Press Club in Washingt...quo;Henninger”) capped off a successful year...
Breaking Medicine News(10 mins):Health News:Feeding Birds in Winter Could Speed Evolution of Species 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 4Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 5Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 6Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 7Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 8Health News:Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza 2Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 2Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 3Health News:The Top Health Stories Of 2009, From The Harvard Health Letter 4Health News:Henninger Media Services Wins 9 TIVA Peer Awards 2Health News:Henninger Media Services Wins 9 TIVA Peer Awards 3
...y be synonymous with milder weather and opening da...Y, a 15-year-old baseball player and sophomore at ...to shut out cancer. , , Mele, a catcher and third...ute Myelogenous Leukemia (AML), a fast-growing can...
...(Nasdaq: GPRO ) announced today that the Company...he Ltd. and Roche Molecular Systems, Inc., has pre... concerning the Company,s supply and purchase agre...pute Resolution issued an interim award that dismi...
...nic Touch(TM) hearing aid is smallest receiver-in-... 1 Sonic Innovations, Inc. (Nasdaq: SNCI ) will...ice, Sonic Touch(TM), at the Audiology NOW! Confer...t available in the market. , , Sonic Touch(TM) i...
...ax Inc. (Nasdaq: NVAX) announced today that ...12.5 million shares of Novavax,s common stock at $...ila Pharmaceuticals as part of the new strategic a... convertible notes due in July 2009 and for a vari...
... for disease therapy, researchers say , , ...on in protein folding contributes to nerve cell de...elp lead to new treatments, Dutch researchers repo...nfolded protein response" typically protects cells...
...he Ribbon Cutting Ceremony, this past Friday, hono...ool of Nursing West Chester campus was a proud and...aff, and students. , , (Photo: http://www.ne... of Hondros College , provided an inspiring speec...
Other Medicine News:Health News:Blood, Marrow Drive Offers Hope for Baseball Player, 15 2Health News:Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement 2Health News:Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement 3Health News:Sonic Innovations Celebrates Company's First Receiver-In-Canal Hearing Aid 2Health News:Sonic Innovations Celebrates Company's First Receiver-In-Canal Hearing Aid 3Health News:Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals 2Health News:Protein-Folding Problem May Help Spur Alzheimer's 2Health News:Hondros College School of Nursing West Chester Campus Opens New Building; Honors Nursing Administrators 2Health News:Hondros College School of Nursing West Chester Campus Opens New Building; Honors Nursing Administrators 3
(Date:12/3/2009)..., Dec. 3 VirtualScopics,...ntitative imaging for clinical trials, announced t... 4D Reconstruction and Visualization" recently rec...e President of Technology and Product Development,...apan has recognized the uniqueness of VirtualScopi...
(Date:12/3/2009)...NG, China, Dec. 3 /PRNewswire-Asia/ -- Simcere Pha...SE: SCR ), a leading pharmaceutical company,spec...rketing of branded,generic and proprietary pharmac...te Food and Drug Administration ("SFDA") has initi...sues regarding human use rabies vaccine (vero,cell...
(Date:12/3/2009)... and NEEDHAM, Massachusetts, December 3 /PRNewswir...change: ORIDN) today announced that the Bavarian R...hs for its RTW (Rettungswagen) medical vehicles. T...assess the ventilation status of a patient as well...tatus such as displaced endotracheal tubes, episod...
Breaking Medicine Technology:VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 1New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 2New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 3New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 4New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 5New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 6Laying Still Raises Artificial Insemination Success 60356 1Laying Still Raises Artificial Insemination Success 60356 2Laying Still Raises Artificial Insemination Success 60356 3
...se III Studies With Ofatumumab, Zalutumumab and Za...S (OMX:,GEN) reports today that the last patient t...32 patients) in the pivotal Phase III clinical tri...onic lymphocytic leukemia,(CLL) has now received t...e the database and allow for assessment of the,res...
...y 28 Robert Brackett, chief,science officer for t...released the following statement in response to th...orted in the latest issue of the Journal of the,Am...he findings reported in today,s issue of the Journ...cating that the rise in,childhood and teen obesity...
Other Medicine Technology:Genmab Announces Updates on Phase III Cancer Studies 2Genmab Announces Updates on Phase III Cancer Studies 3
...stem combines the longest available wavelength wit...afety and efficacy. The unique flat beam profile c...ge to all targeted structures. The Lyra-I uniquely...All Lyra-I patients are protected by patented cont...
... Aura-i Laser System is a compact, highly portable...d procedures. Its unique, integrated StarPulse fea...r, including telangiectasia on the leg and face, a... It can also be used as a continuous wave laser fo...
Surgisis® IHM™ Inguinal Hernia Matrix
Surgisis® GOLD™ Hernia Repair Grafts
Medicine Products: